Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: a randomized, open-label, phase IIb, 5-year study in Indian patients (Q87419417)
Jump to navigation
Jump to search
scientific article published on 06 March 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: a randomized, open-label, phase IIb, 5-year study in Indian patients |
scientific article published on 06 March 2014 |
Statements
Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: a randomized, open-label, phase IIb, 5-year study in Indian patients (English)
B K M Reddy
V Lokesh
M S Vidyasagar
K Shenoy
K G Babu
A Shenoy
T Naveen
R Bonanthaya
Nanjundappa
P P Bapsy
Loknatha
Jayarama Shetty
Krishna Prasad